Insight Molecular Diagnostics, Inc. (IMDX)
2.49
+0.03
(+1.22%)
USD |
NASDAQ |
Nov 06, 16:00
2.50
+0.01
(+0.40%)
After-Hours: 20:00
Insight Molecular Diagnostics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 29, 2025 | 84.18 |
| September 26, 2025 | 86.79 |
| September 25, 2025 | 84.96 |
| September 24, 2025 | 85.36 |
| September 23, 2025 | 78.45 |
| September 22, 2025 | 85.23 |
| September 19, 2025 | 88.87 |
| September 18, 2025 | 87.83 |
| September 17, 2025 | 86.27 |
| September 16, 2025 | 89.66 |
| September 15, 2025 | 80.53 |
| September 12, 2025 | 80.27 |
| September 11, 2025 | 82.88 |
| September 10, 2025 | 78.19 |
| September 09, 2025 | 69.59 |
| September 08, 2025 | 64.90 |
| September 05, 2025 | 64.64 |
| September 04, 2025 | 64.38 |
| September 03, 2025 | 66.72 |
| September 02, 2025 | 67.76 |
| August 29, 2025 | 65.94 |
| August 28, 2025 | 65.42 |
| August 27, 2025 | 64.64 |
| August 26, 2025 | 65.42 |
| August 25, 2025 | 64.90 |
| Date | Value |
|---|---|
| August 22, 2025 | 67.50 |
| August 21, 2025 | 64.64 |
| August 20, 2025 | 65.16 |
| August 19, 2025 | 67.76 |
| August 18, 2025 | 69.59 |
| August 15, 2025 | 62.55 |
| August 14, 2025 | 62.55 |
| August 13, 2025 | 63.85 |
| August 12, 2025 | 65.42 |
| August 11, 2025 | 68.02 |
| August 08, 2025 | 66.98 |
| August 07, 2025 | 68.42 |
| August 06, 2025 | 69.07 |
| August 05, 2025 | 68.02 |
| August 04, 2025 | 72.19 |
| August 01, 2025 | 66.72 |
| July 31, 2025 | 65.68 |
| July 30, 2025 | 70.37 |
| July 29, 2025 | 71.15 |
| July 28, 2025 | 72.72 |
| July 25, 2025 | 75.19 |
| July 24, 2025 | 77.15 |
| July 23, 2025 | 78.45 |
| July 22, 2025 | 74.02 |
| July 21, 2025 | 78.97 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Perspective Therapeutics, Inc. | 0.2959 |
| Agenus, Inc. | -- |
| Amgen, Inc. | 17.35 |
| Anika Therapeutics, Inc. | 1.416 |
| BioCryst Pharmaceuticals, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 50.46 |
| Price | 2.49 |
| Earnings Yield | -59.65% |
| Market Cap | 81.23M |